A
Amber Woolfenden
Researcher at Novartis
Publications - 10
Citations - 2491
Amber Woolfenden is an academic researcher from Novartis. The author has contributed to research in topics: Neovascularization & Angiogenesis. The author has an hindex of 8, co-authored 10 publications receiving 2346 citations. Previous affiliations of Amber Woolfenden include Massachusetts Institute of Technology.
Papers
More filters
Journal ArticleDOI
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Carla F. Kim,Erica L. Jackson,Amber Woolfenden,Sharon Lawrence,Imran Babar,Sinae Vogel,Denise Crowley,Roderick T. Bronson,Tyler Jacks +8 more
TL;DR: Although bronchiolar cells and alveolar cells are proposed to be the precursor cells of adenocarcinoma, this work points to bronchioalveolar stem cells as the putative cells of origin for this subtype of lung cancer.
Journal ArticleDOI
Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells
Stephen J. Curtis,Kerstin W. Sinkevicius,Kerstin W. Sinkevicius,Danan Li,Danan Li,Allison N. Lau,Allison N. Lau,Rebecca R. Roach,Rebecca R. Roach,Raffaella Zamponi,Raffaella Zamponi,Amber Woolfenden,David G. Kirsch,Kwok-Kin Wong,Kwok-Kin Wong,Carla F. Kim,Carla F. Kim +16 more
TL;DR: The studies show that the genotype of tumor samples must be considered in studies to identify, characterize, and target tumor-propagating cells.
Journal ArticleDOI
Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration
Rose Nolen-Walston,Carla F. Kim,Melissa R. Mazan,Edward P. Ingenito,Alisha M. Gruntman,Larry W. Tsai,Raymond C. Boston,Amber Woolfenden,Tyler Jacks,Andrew M. Hoffman +9 more
TL;DR: The model demonstrated that BASC proliferation and differentiation contributes between 0 and 25% of compensatory alveolar epithelial (type I and II cell) regrowth, demonstrating that regeneration requires a substantial contribution from AECII.
Journal ArticleDOI
Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation.
Stephen Poor,Yubin Qiu,Elizabeth Fassbender,Siyuan Shen,Amber Woolfenden,Andrea Delpero,Yong Kim,Natasha Buchanan,Thomas C. Gebuhr,Shawn Hanks,Erik Meredith,Bruce D Jaffee,Thaddeus P. Dryja +12 more
TL;DR: The recommended methods for conducting experiments with the mouse laser-induced CNV model are presented to enhance reproducibility and minimize investigator bias.
Journal ArticleDOI
Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration.
Erik Meredith,Nello Mainolfi,Stephen Poor,Yubin Qiu,Karl Miranda,Powers James J,Donglei Liu,Fupeng Ma,Catherine Solovay,Chang Rao,Leland Johnson,Nan Ji,Gerald D. Artman,Leo A. Hardegger,Shawn Hanks,Siyuan Shen,Amber Woolfenden,Elizabeth Fassbender,Jeremy M Sivak,Yiqin Zhang,Debby Long,Rosemarie Cepeda,Fang Liu,Vinayak Hosagrahara,Wendy Lee,Peter Tarsa,Karen Anderson,Jason Elliott,Bruce D Jaffee +28 more
TL;DR: This work employed a high-throughput in vivo screening strategy with rodent models of choroidal neovascularization and iterative compound design to identify VEGFR-2 inhibitors with potential to benefit wet AMD patients, and these compounds demonstrate preferential ocular tissue distribution and efficacy after oral administration while minimizing systemic exposure.